Skip to main content
. 2024 Feb 1;15:1355128. doi: 10.3389/fimmu.2024.1355128

Figure 2.

Figure 2

ABOi patients showed significantly higher risk for the development of ABMR as compared to ABOc patients, but similar outcomes regarding TCMR, graft survival and overall survival. Cumulative incidence of ABMR (A), TCMR (B), death-censored graft survival (C), and overall patient survival (D) in the ABOc and ABOi patients respectively. Log-rank test was used to test p value of the Kaplan-Meier survival curves for (A–D).